ArticleOncology letters2022

Concurrent TP53 mutations predict a poor prognosis of EGFR-mutant NSCLCs treated with TKIs: An updated systematic review and meta-analysis.

Bo Lan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.